Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Roberta Maroni"'
Autor:
Bhagabati Ghimire, Rebecca Landy, Roberta Maroni, Samuel G. Smith, Irene Debiram-Beecham, Peter D. Sasieni, Rebecca C. Fitzgerald, Greg Rubin, Fiona M. Walter, Jo Waller, BEST3 Consortium, Judith Offman
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background The Cytosponge is a cell-collection device, which, coupled with a test for trefoil factor 3 (TFF3), can be used to diagnose Barrett’s oesophagus, a precursor condition to oesophageal adenocarcinoma. BEST3, a large pragmatic, ran
Externí odkaz:
https://doaj.org/article/968c93dd7d784bc4a524805f603e686b
Autor:
Samuel G Smith, Jo Waller, Fiona M Walter, Peter Sasieni, Rebecca C Fitzgerald, Irene Debiram-Beecham, Greg Rubin, Judith Offman, Fiona Scheibl, Jessica Barnes, Roberta Maroni
Publikováno v:
BMJ Open, Vol 12, Iss 4 (2022)
Objectives The BEST3 trial demonstrated the efficacy and safety of the Cytosponge-trefoil factor 3, a cell collection device coupled with the biomarker trefoil factor 3, as a tool for detecting Barrett’s oesophagus, a precursor of oesophageal adeno
Externí odkaz:
https://doaj.org/article/3d7a260d023c421ba20c8a70d62ae37e
Autor:
Nicholas Swart, Roberta Maroni, Beth Muldrew, Peter Sasieni, Rebecca C. Fitzgerald, Stephen Morris
Publikováno v:
EClinicalMedicine, Vol 37, Iss , Pp 100969- (2021)
Background: Esophageal adenocarcinoma has a very poor prognosis unless detected early. The Cytosponge-trefoil factor 3 (TFF3) is a non-endoscopic test for Barrett esophagus, a precursor of esophageal adenocarcinoma. Randomised controlled trial data f
Externí odkaz:
https://doaj.org/article/2aac5b043da6416a9ef4075b7e95a72a
Autor:
W Keith Tan, Roberta Maroni, Judith Offman, Massimiliano di Pietro, Judith Honing, Maria O’Donovan, Peter Sasieni, Rebecca Fitzgerald
Publikováno v:
Oral presentations.
Autor:
Roberta Maroni, Dharmishta Parmar, Stephen W. Duffy, Jack Cuzick, Amanda Dibden, Nathalie J. Massat, Peter Sasieni
Publikováno v:
British Journal of Cancer
BackgroundOver the past 30 years since the implementation of the National Health Service Breast Screening Programme, improvements in diagnostic techniques and treatments have led to the need for an up-to-date evaluation of its benefit on risk of deat
Autor:
Stephen Morris, Peter Sasieni, Rebecca C. Fitzgerald, Beth Muldrew, Nicholas Swart, Roberta Maroni
Publikováno v:
EClinicalMedicine
EClinicalMedicine, Vol 37, Iss, Pp 100969-(2021)
EClinicalMedicine, Vol 37, Iss, Pp 100969-(2021)
BackgroundEsophageal adenocarcinoma has a very poor prognosis unless detected early. The Cytosponge-trefoil factor 3 (TFF3) is a non-endoscopic test for Barrett esophagus, a precursor of esophageal adenocarcinoma. Randomised controlled trial data fro
Autor:
Grace Hsiao Hsuan Jen, Sven Törnberg, László Tabár, Sam Li Sheng Chen, Sherry Yueh Hsia Chiu, Chen Yang Hsu, Johan Ahlgren, Tony Hsiu Hsi Chen, Robert A. Smith, Lars Holmberg, May Mei Sheng Ku, Stephen W. Duffy, Håkan Jonsson, Peter B. Dean, Amy Ming-Fang Yen, Roberta Maroni
Background: Previously, the risk of death from breast cancer was analyzed for women participating versus those not participating in the last screening examination before breast cancer diagnosis. Consecutive attendance patterns may further refine esti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f245850dd32f94c996b5d8dbb3627c43
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-447101
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-447101
Autor:
Beth Muldrew, Rebecca C. Fitzgerald, Stephen Morris, Nicholas Swart, Roberta Maroni, Peter Sasieni
Publikováno v:
SSRN Electronic Journal.
Background: Oesophageal adenocarcinoma (EAC) has a very poor prognosis unless detected early. The Cytosponge-trefoil factor 3 (TFF3) is a non-endoscopic test for Barrett’s oesophagus, a precursor of EAC. Randomised controlled trial data from the BE
Autor:
Daniel Vulkan, Rachel Arvanitis, Karen Fitzgerald, Michelle Timoney, S Hill, Katy Gardner, Linda Lukehirst, Martin Ledson, John K. Field, Veronique Poirier, Paul Rutherford, D Fidoe, Faye Clarke, Bhagabati Ghimire, Samantha L Quaife, S. Mason, E Gaynor, Roberta Maroni, Samuel G. Smith, Stephen W. Duffy, Lisa Jones, Michael W. Marcus, Zoheb Shah
Publikováno v:
LUNG CANCER
Objectives This Liverpool Healthy Lung Programme is a response to high rates of lung cancer and respiratory diseases locally and aims to diagnose lung cancer at an earlier stage by proactive approach to those at high risk of lung cancer. The objectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb789b377d8a3ec96ff61cd9c5418341
Autor:
Marcel Gehrung, Maria O'Donovan, Irene Debiram-Beecham, Samuel G. Smith, Massimiliano di Pietro, Judith Offman, Laura Baseley, Roberta Maroni, Benoit Aigret, Peter Sasieni, Beth Muldrew, Greg Rubin, Fiona M Walter, Francesca Pesola, Rebecca C. Fitzgerald
Publikováno v:
Gastroenterology. 158:S-136